- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07946809
Periodontal Health and Treatment Outcomes in Students From Three Countries
Investigation of the Prevalence, Severity, and Treatment Response of Periodontal Diseases Among Student Groups From Different Countries
This study aims to investigate the prevalence and severity of periodontal diseases among university students from three different national backgrounds (Iranian, Sudanese, and Turkish) and to evaluate their response to periodontal treatment.
A total of 348 students will be included in the study, comprising 116 Iranian, 116 Sudanese, and 116 Turkish students. Periodontal health assessments will be performed, and all participants will receive periodontal treatment according to the study protocol.
The study will compare periodontal disease prevalence and severity among the three groups and evaluate changes in periodontal health following treatment.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This study investigates the prevalence and severity of periodontal diseases among university students from three different national backgrounds and evaluates their response to periodontal treatment.
A total of 348 university students will be included in the study, consisting of 116 students of Iranian origin, 116 students of Sudanese origin, and 116 students of Turkish origin.
At baseline, all participants will undergo a comprehensive periodontal examination to assess their periodontal health status. Clinical periodontal parameters will be recorded using standardized periodontal assessment methods.
All participants will receive periodontal treatment according to the study protocol. The treatment includes professional scaling and oral hygiene instruction. Root planing will be performed when clinically indicated, depending on the periodontal condition of each participant.
Three weeks after treatment, participants will undergo a follow-up periodontal examination. Clinical periodontal parameters will be reassessed to evaluate changes in periodontal health and treatment response.
The findings will be compared among the three student groups to investigate differences in periodontal disease prevalence, severity, and response to treatment.
The study aims to provide information about periodontal health differences among students from different national backgrounds and their response to periodontal treatment.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Esra İlkerli Şençağlı, Dt.
- Telefoonnummer: +905338408701
- E-mail: esra.ilkerli@kstu.edu.tr
Studie Locaties
-
-
-
Mórfou, Cyprus
- Werving
- Cyprus Health and Social Sciences University
-
Contact:
- Esra İlkerli Şençağlı
- Telefoonnummer: +905338408701
- E-mail: esra.ilkerli@kstu.edu.tr
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Being 18 years of age or older.
- Having been born and raised in a country different from the country of current study.
- Currently being enrolled as a student at Cyprus Health and Social Sciences University.
- Having received no periodontal treatment within the previous six months.
- Having at least 20 natural teeth.
- Voluntarily agreeing to participate in the study and providing written informed consent.
Exclusion Criteria:
- Completely edentulous individuals.
- Individuals who have used systemic antibiotics or anti-inflammatory medications within the previous six months.
- Individuals with a history of periodontal surgery.
- Pregnant or breastfeeding individuals.
- Individuals with immunosuppression due to systemic diseases or medical conditions (e.g., chemotherapy or HIV).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Periodontal Treatment Group
All 348 participants will receive periodontal treatment according to their individual clinical needs. Treatment will include scaling and root planing when clinically indicated. Participants will be evaluated at baseline and reassessed three weeks after treatment to assess periodontal treatment outcomes. |
Participants will receive non-surgical periodontal treatment according to their individual clinical needs. The treatment will include scaling and root planing where clinically indicated. The procedure will be performed based on baseline periodontal examination findings. All participants will be reassessed three weeks after treatment to evaluate changes in periodontal clinical parameters, including plaque index, gingival index, probing pocket depth, clinical attachment level, and tooth mobility. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Probing Pocket Depth (PPD)
Tijdsspanne: Baseline and 3 weeks after periodontal treatment
|
Change in mean probing pocket depth (PPD) from baseline to the three-week follow-up after periodontal treatment. Measurements will be compared among Iranian, Sudanese, and Turkish student groups. |
Baseline and 3 weeks after periodontal treatment
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Plaque Index (PI) Assessed Using the Silness and Löe Plaque Index
Tijdsspanne: Baseline and 3 weeks
|
Dental plaque will be assessed clinically using the Silness and Löe Plaque Index (1964). Plaque accumulation will be scored on a scale ranging from 0 to 3: 0: No plaque.
The minimum score is 0 and the maximum score is 3. Higher scores indicate greater plaque accumulation and a worse oral hygiene outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Gingival Index (GI) Assessed Using the Löe and Silness Gingival Index
Tijdsspanne: Baseline and 3 weeks
|
Gingival inflammation will be assessed clinically using the Löe and Silness Gingival Index (1963). Gingival tissues will be scored on a scale ranging from 0 to 3: 0: Normal gingiva, no inflammation.
The minimum score is 0 and the maximum score is 3. Higher scores indicate more severe gingival inflammation and a worse periodontal outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Clinical Attachment Level (CAL)
Tijdsspanne: Baseline and 3 weeks
|
Baseline and 3 weeks
|
|
|
Change in Tooth Mobility Assessed Using the Miller Mobility Index
Tijdsspanne: Baseline and 3 weeks
|
Tooth mobility will be assessed clinically using the Miller Mobility Index. Each examined tooth will be evaluated for horizontal and vertical mobility using two rigid instrument handles. Mobility will be classified as follows: Grade 0: Physiologic tooth mobility. Grade 1: Slight horizontal mobility of less than 1 mm. Grade 2: Horizontal mobility of more than 1 mm without vertical mobility. Grade 3: Severe horizontal mobility accompanied by vertical mobility. Higher grades indicate greater tooth mobility and a worse periodontal outcome. Tooth mobility will be assessed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Bleeding on Probing (BOP) Percentage
Tijdsspanne: Baseline and 3 weeks
|
Bleeding on probing (BOP) will be assessed as a clinical indicator of gingival inflammation using a periodontal probe. The periodontal probe will be gently inserted into the gingival sulcus to evaluate the presence or absence of bleeding following probing. Each periodontal site will be recorded using a dichotomous scoring system: Score 0: Absence of bleeding on probing. Score 1: Presence of bleeding on probing. The BOP percentage will be calculated by dividing the total number of bleeding-positive sites by the total number of examined periodontal sites and multiplying by 100. BOP (%) = (Number of bleeding-positive sites / Total number of examined sites) × 100. The minimum value is 0% and the maximum value is 100%. Higher percentages indicate a greater proportion of bleeding sites and more pronounced gingival inflammation. |
Baseline and 3 weeks
|
|
Prevalence and Severity of Periodontal Disease
Tijdsspanne: Baseline
|
Baseline
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie stoel: Halil İbrahim Taşer, Prof.Dr., Cyprus Health and Social Sciences University
- Hoofdonderzoeker: Esra İlkerli Şençağlı, Dt., Cyprus Health and Social Sciences University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Mondziekten
- Stomatognatische ziekten
- Infecties
- Tandvleesaandoeningen
- Parodontitis
- Parodontale aandoeningen
- Gingivitis
- Spijsverteringssysteem en orale fysiologische fenomenen
- Tandheelkunde
- Tandheelkundig fysiologische fenomenen
- Tandschaling
- Tandheelkundige profylaxe
- Parodontie
- Subgingival curettage
- Preventieve tandheelkunde
- Wortelplanning
- Tandafschilfering
Andere studie-ID-nummers
- ESRA-PERIO-001
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .